Acquired Deficiency of A20 Results in Rapid Apoptosis, Systemic Inflammation, and Abnormal Hematopoietic Stem Cell Function
Akiko Nagamachi(Hiroshima University), Hiroaki Honda(Tokyo Women's Medical University), Norimasa Yamasaki(Hiroshima University), Toshiya Inaba(Hiroshima University), Keiyo Takubo(Keio University), Toshio Suda(Chinese Academy of Sciences), Yasuhiro Ebihara(Saitama Medical University), Takeshi Ueda(Kindai University), Yuichiro Nakata(University of Miami), Kohichiro Tsuji(Tokyo Medical University), Hideaki Oda(Hakodate Central General Hospital), Zen-ichiro Honda(Ochanomizu University)
Cited by 25
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694